Candesartan cilexetil
Carzap and Candesartan Zentiva are different trade names for the same medicine.
Table of Contents of the Leaflet:
The name of the medicine is Carzap. The active substance is candesartan cilexetil. It belongs to a group of medicines called angiotensin II receptor antagonists. It causes relaxation and dilation of blood vessels. This helps to lower blood pressure. The medicine also makes it easier for the heart to pump blood to all parts of the body.
Carzap is used:
In case of doubt, whether any of the above situations apply to the patient, they should consult a doctor or pharmacist before taking Carzap.
Before starting to take Carzap, the patient should discuss it with their doctor or pharmacist:
The doctor may monitor kidney function, blood pressure, and electrolyte levels (such as potassium) in the blood at regular intervals.
See also the information under the heading "When not to take Carzap".
If any of the above conditions apply to the patient, the doctor may recommend more frequent checks and tests.
If the patient is going to have surgery, they should inform their doctor or dentist that they are taking Carzap. This is because Carzap, in combination with certain anesthetics, may cause excessive lowering of blood pressure.
Studies have been conducted on the use of candesartan cilexetil in children. For further information, the patient should consult their doctor. Carzap should not be given to children under 1 year of age due to the potential risk to kidney development.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Carzap may affect the action of other medicines, and other medicines may affect Carzap. If the patient is taking certain medicines, the doctor may periodically recommend blood tests.
In particular, the patient should inform their doctor if they are taking any of the following medicines:
The doctor may need to change the dose and/or take other precautions:
While taking Carzap, the patient should consult their doctor if they plan to consume alcohol. Alcohol may cause dizziness or fainting.
Pregnancy
If the patient suspects that they may be pregnant (or plans to have a child), they should consult their doctor. The doctor will usually recommend stopping Carzap before planned pregnancy or as soon as pregnancy is confirmed, and recommend taking another medicine instead of Carzap. It is not recommended to take Carzap in early pregnancy and it should not be taken after 3 months of pregnancy, as it may seriously harm the baby.
Breastfeeding
The patient should inform their doctor if they are breastfeeding or plan to breastfeed. It is not recommended to take Carzap while breastfeeding, especially in the case of breastfeeding a newborn or premature baby. The doctor may recommend taking another medicine.
While taking Carzap, some patients may feel tired and dizzy. If such symptoms occur, the patient should not drive, use tools, or operate machines.
Carzap contains lactose monohydrate, which is a type of sugar. If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking Carzap.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
Carzap is available in the following strengths: 8 mg, 16 mg, and 32 mg.
This medicine should always be taken as directed by the doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist .It is important to take Carzap every day.
Carzap can be taken with or without food.
The tablet should be swallowed with water.
Tablets should be taken every day at about the same time. This will help the patient remember to take their dose.
The recommended initial dose is 4 mg once daily.
Patients with a body weight of less than 50 kg: in patients whose blood pressure is not adequately controlled, the doctor may decide to increase the dose to a maximum of 8 mg once daily.
Patients with a body weight of 50 kg or more: in patients whose blood pressure is not adequately controlled, the doctor may decide to increase the dose to 8 mg once daily, and then to 16 mg once daily.
The recommended initial dose of Carzap is 4 mg once daily. The doctor may increase the dose by doubling it, at intervals of at least 2 weeks, to 32 mg once daily. Carzap can be taken with other medicines used to treat heart failure, and the doctor will decide which treatment is most suitable for the patient.
In case of use of a higher dose of Carzap than recommended by the doctor, the patient should immediately contact their doctor or pharmacist.
The patient should not take a double dose to make up for a missed dose. They should take the next dose at the usual time.
If treatment with Carzap is stopped, blood pressure may increase again.
Therefore, the patient should not stop taking Carzap without first consulting their doctor.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist .
Like all medicines, Carzap can cause side effects, although not everybody gets them.
It is important for the patient to know that they can occur.
Carzap may cause a decrease in the number of white blood cells. The patient's resistance to infection may be decreased, and they may experience fatigue, infection, or fever. If such symptoms occur, the patient should contact their doctor. The doctor may recommend periodic blood tests to check if Carzap is affecting the blood (agranulocytosis).
Other possible side effects include:
In children treated for high blood pressure, side effects seem to be similar to those in adults, but they occur more frequently. A very common side effect in children that was not reported in adults is sore throat, and other side effects such as runny nose, fever, and rapid heartbeat in children occur frequently, while in adults they were not reported.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed .This will help protect the environment.
The active substance is candesartan cilexetil. Each tablet contains 32 mg of candesartan cilexetil.
The other ingredients are: lactose monohydrate, cornstarch, hydroxypropylcellulose (E 463), croscarmellose sodium (E 468), magnesium stearate (E 572), triethyl citrate (E 1505).
Carzap, 32 mg, is a round, biconvex, white or almost white tablet with a score line on one side and the imprint C/32 on the same side. The diameter of the tablet is approximately 10.5 mm.
The tablet can be divided into equal doses.
Pack size: 28 tablets.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Zentiva Portugal, Lda
Miraflores Premium I
Alameda Fernão Lopes, 16 A - 8º piso A
1495-190 Algés
Portugal
Siegfried Malta Ltd
HHF070 Hal Far Industrial Estate
P.O. box 14
Hal Far BBG 3000
Malta
Zentiva k.s.
U kabelovny 130
102 37, Prague 10 - Dolní Měcholupy
Czech Republic
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Authorization number in Portugal, the country of export:5404561
Parallel import authorization number:181/21
Date of approval of the leaflet: 05.10.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.